Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
MARKET INSIGHTS
The global Salmonella Testing market size was valued at USD 672.5 million in 2024. The market is projected to grow from USD 712.8 million in 2025 to USD 1.15 billion by 2031, exhibiting a CAGR of 7.1% during the forecast period.
Salmonella testing refers to diagnostic procedures used to detect Salmonella bacteria in food samples, clinical specimens, and environmental sources. These tests include traditional culture methods, rapid immunoassays, and advanced molecular techniques such as PCR and next-generation sequencing. The increasing focus on food safety regulations and the rising incidence of salmonellosis worldwide are key factors driving market growth.
The market is experiencing steady expansion due to stringent food safety standards implemented by regulatory bodies like the FDA and EFSA. Additionally, technological advancements in testing methodologies, particularly the shift toward rapid detection systems, are accelerating market adoption. However, high costs associated with advanced testing equipment may restrain growth in developing regions. Key players such as Thermo Fisher Scientific, Bio-Rad Laboratories, and 3M are investing heavily in R&D to launch innovative testing solutions, further fueling market competition.
Increasing Food Safety Regulations Worldwide
The global salmonella testing market is primarily driven by stringent food safety regulations imposed by governments and regulatory bodies. The FDA, EFSA, and other agencies have mandated rigorous testing protocols, with the global food safety testing market expected to grow at 7.5% CAGR through 2030. Mandatory HACCP implementation in food processing has significantly increased demand for salmonella detection.
Rising Incidence of Foodborne Illness Outbreaks
Recent high-profile salmonella outbreaks linked to poultry, eggs, and fresh produce have heightened public awareness. The CDC reports approximately 1.35 million salmonella infections annually in the US alone, driving demand for more effective testing solutions. Food recalls due to salmonella contamination have increased by 30% over the past five years.
Advanced PCR-based testing methods now account for over 45% of salmonella tests in developed markets, replacing traditional culture methods.
The growing processed food industry, valued at $7 trillion globally, is also contributing to market growth as manufacturers implement more rigorous testing protocols throughout the supply chain.
MARKET CHALLENGES
High Cost of Advanced Testing Equipment
Implementation of rapid testing technologies like PCR and immunoassays requires significant capital investment, with automated systems costing $35,000-$150,000. Many small and medium food processors struggle with these upfront costs, limiting market penetration in developing regions.
Other Challenges
Time Sensitivity of Results
Despite technological advancements, most salmonella tests still require 24-72 hours for confirmed results, creating logistical challenges for perishable food supply chains.
Regulatory Divergence
Differences in testing requirements between regions like the US, EU, and Asia-Pacific complicate compliance for multinational food companies.
Limited Adoption in Developing Markets
While developed nations have strict salmonella testing mandates, many emerging economies lack enforcement capabilities. Only 40% of low-income countries have implemented national food safety testing programs, constraining market growth in these regions.
Point-of-Care Testing Innovations
Emerging biosensor technologies capable of detecting salmonella in under 6 hours present significant growth potential. The portable food pathogen testing device market is projected to reach $850 million by 2028, opening new applications in field testing and agricultural settings.
Expansion in Meat and Poultry Sector
With poultry accounting for 40% of salmonella contamination cases, meat processors are investing heavily in testing solutions. The segment is expected to maintain 8.2% annual growth through 2030 as major producers implement farm-to-retail testing protocols.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Molecular Diagnostics leads due to rapid advancements in PCR technologies and their high sensitivity in detecting Salmonella strains. The growing preference for rapid diagnostic solutions in food safety regulations continues to drive adoption. Immunoassays remain popular for routine screening due to their cost-effectiveness, while monoclonal antibodies see specialized use in research applications. |
| By Application |
|
Public Health Labs dominate as primary testing centers due to mandatory foodborne illness surveillance programs. Commercial labs show strong growth with increasing outsourcing of food testing by manufacturers. Hospitals focus more on clinical diagnosis of salmonellosis cases, while physician offices handle preliminary screening before referral to specialized facilities. |
| By End User |
|
Food Manufacturers represent the largest segment due to stringent food safety regulations globally, particularly in meat and poultry processing. Healthcare providers focus on clinical diagnostics for human infections, while research institutions drive innovation in testing methodologies. Government agencies utilize testing for outbreak surveillance and regulatory compliance enforcement. |
| By Technology Adoption |
|
Rapid Testing Kits show the highest growth trajectory due to their time efficiency and ease of use in field applications. While traditional methods remain the gold standard for confirmatory testing, automation gains traction in high-volume testing environments. The market shows distinct technology adoption patterns between routine screening needs and confirmatory diagnostic requirements. |
| By Regulatory Environment |
|
FDA-Regulated Markets drive technological innovation with rigorous performance standards for Salmonella detection. EU markets emphasize harmonized testing protocols across member states, while emerging markets show increasing adoption of international standards. Regulatory divergence creates distinct market dynamics that influence product development strategies across regions. |
Global Leaders Driving Salmonella Testing Innovation
The Salmonella testing market is dominated by established diagnostics giants such as Roche, Hologic/Gen-Probe, and Qiagen, which collectively hold over 40% of global market share. These market leaders are focusing on molecular diagnostics and automated solutions to maintain their competitive edge, with Roche leading in PCR-based testing and Hologic/Gen-Probe excelling in nucleic acid amplification technologies.
Emerging players like Scienion and Sequenom are making significant strides in next-generation sequencing applications for Salmonella detection, particularly in food safety applications. Regional specialists such as Fujirebio in Asia and Ortho-Clinical Diagnostics in North America maintain strong positions in their respective markets through specialized immunoassay offerings.
List of Key Salmonella Testing Companies ProfiledEnzo Biochem
Grifols
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Scienion
Sequenom
SeraCare
bioMrieux
The global Salmonella testing market was valued at $1.2 billion in 2024 and is projected to reach $1.8 billion by 2031, growing at a CAGR of 5.7%. Molecular diagnostics represents the fastest-growing segment, expected to reach $650 million by 2031 with a 7.2% CAGR. This growth is driven by increasing demand for rapid, accurate pathogen detection in food safety and clinical diagnostics.
Other TrendsRegional Market Development
The U.S. market leads with $450 million in 2024 valuations, while China follows with $280 million, projected to grow at 6.9% CAGR. Europe and Asia-Pacific regions show strong growth potential due to stricter food safety regulations and increased healthcare spending. The Asia-Pacific region is particularly driven by Japan, South Korea and developing Southeast Asian markets.
Competitive Landscape ConsolidationKey players including Roche, Qiagen, and Hologic/Gen-Probe dominate the market, collectively holding 45% global revenue share. Recent mergers and acquisitions among diagnostic companies aim to expand testing portfolios and geographic reach. The market sees increasing R&D investments in next-generation sequencing and automated testing platforms.
Application Sector Growth
Hospital laboratories account for 38% of testing volume, followed by public health labs at 29%. The physician offices segment shows the fastest growth (6.5% CAGR) due to point-of-care testing adoption. Food industry applications are driving expansion in commercial/private lab testing services.
Technological AdvancementsThe market is shifting toward multiplex PCR and microarray platforms that enable simultaneous detection of multiple pathogens. Immunoassay and monoclonal antibody technologies maintain stable growth at 4.3% CAGR. Emerging differential light scattering technology shows promise for rapid, label-free detection with a projected 18% annual growth rate.
Regional Analysis: Salmonella Testing MarketEurope
Europe maintains robust Salmonella testing protocols, particularly in poultry products where EU-wide control programs exist. The European Food Safety Authority coordinates harmonized testing methodologies across member states. Strict import/export regulations drive testing demand in food processing plants. Northern European countries lead in adopting novel detection technologies, while Southern Europe shows gradual modernization of testing infrastructure. The region's focus on antibiotic-resistant Salmonella strains influences testing method development. EU funding supports research into alternative detection platforms beyond traditional culture methods.
Asia-Pacific
Asia-Pacific exhibits the fastest growth in Salmonella testing due to expanding food safety regulations. China's increased scrutiny on food exports has boosted testing volumes significantly. India's growing middle class demands better food safety measures, driving market expansion. Australia and New Zealand maintain world-class testing standards for agricultural exports. The region shows particular interest in cost-effective rapid tests suitable for small-scale producers. Local manufacturers are developing region-specific testing solutions to compete with multinational corporations.
South America
South America's Salmonella testing market centers around meat exports, particularly poultry to international markets. Brazil's large-scale agriculture drives demand for high-throughput testing solutions. Regional variations exist, with Southern Cone countries maintaining more advanced testing infrastructure than northern nations. Increasing domestic awareness of foodborne illnesses creates new testing opportunities. Economic fluctuations sometimes constrain public health testing budgets. Local authorities are working to align testing standards with major export destinations to maintain market access.
Middle East & Africa
The Middle East relies heavily on imported food, driving border inspection testing programs. Gulf Cooperation Council countries implement stringent import testing protocols. Africa shows growing recognition of Salmonella as public health priority, though testing capacity remains limited outside major urban centers. International food safety initiatives are helping build basic testing capabilities. The halal food industry incorporates Salmonella testing as part of quality assurance. Climate change impacts on food safety may increase testing requirements in coming years.
This market research report offers a holistic overview of global and regional markets for the forecast period 20252032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Pharmaceutical and biotech companies
Medical device and diagnostics manufacturers
Healthcare providers and hospital systems
Contract research and manufacturing organizations
Investors, consultants, and policy makers
-> Global Salmonella Testing market was valued at USD 672.5 million in 2024 and is expected to reach USD 1.15 billion by 2031.
Which key companies operate in Global Salmonella Testing Market?
-> Key players include Enzo Biochem, Fujirebio, Grifols, Hologic/Gen-Probe, ID Biomedical/GSK, Qiagen, and Roche, among others.
-> The market is projected to grow at a CAGR of 7.1% during the forecast period.
-> North America currently leads the market, with the U.S. as the largest contributor.
-> Key segments include molecular diagnostics, monoclonal antibodies, immunoassays, and differential light scattering technologies.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates